CSIIのニュース
Cytek Biosciences Set to Join S&P SmallCap 600 2023/04/25 21:54:00 PR Newswire
NEW YORK, April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, May 1. S&P 500 and 100 constituent Abbott Laboratories (NYSE:ABT) is acquiring…
Recent Filing Shows That Sen. Tina Smith Sold Over $100K Worth of Cardiovascular Systems Stock 2023/04/20 15:05:10 Benzinga
The Office of Senator Tina Smith has reported a sale of Cardiovascular Systems (NASDAQ: CSII ) stock on April 19, 2023. According to the April filing, the transaction was made on April 19, 2023. What Happened: A recent report from the U.S. Senate''s Office on April 19, 2023 reveals that Smith made a sale of Cardiovascular Systems stock valued between $100,002 - $200,000. Cardiovascular Systems shares are trading down 0.0% at $19.97 at the time of writing. The Importance of Congressional Transactions Congressional transactions shouldn''t be used primarily to make an investing decision, however, they can … Full story available on Benzinga.com
How should investors view Cardiovascular Systems Inc. (CSII)? 2023/02/20 18:00:00 US Post News
Within its last year performance, CSII fell by -0.71%, with highs and lows ranging from $23.47 to $12.26, whereas the simple moving average jumped by 34.36% in the last 200 days. On December 21, 2022, Barclays started tracking Cardiovascular Systems Inc. (NASDAQ: CSII) recommending Equal Weight. A report published by Lake Street on December 14, […]
Abbott Acquires Cardiovascular Systems: Key Takeaways For Investors 2023/02/15 21:57:10 Seeking Alpha
Abbott Laboratories expands its cardiovascular pipeline with its acquisition of Cardiovascular Systems, Inc. Click here for our take on what this means for ABT.
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Cardiovascular Systems, Inc. - CSII 2023/02/14 00:41:00 PR Newswire
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered…
Cardiovascular Systems, Inc. 2023 Q1 - Results - Earnings Call Presentation (NASDAQ:CSII) 2022/11/16 19:14:07 Seeking Alpha
The following slide deck was published by Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. (CSII) Q1 2023 Earnings Call Transcript 2022/11/05 17:58:03 Seeking Alpha
Cardiovascular Systems, Inc. (NASDAQ:NASDAQ:CSII) Q1 2023 Results Conference Call November 03, 2022 09:00 AM ET Company Participants Jack Nielsen - Vice President of Investor Relations…
Cardiovascular Systems GAAP EPS of -$0.27 misses by $0.04, revenue of $59.67M beats by $0.33M 2022/11/03 11:14:32 Seeking Alpha
Cardiovascular Systems press release (CSII): Q1 GAAP EPS of -$0.27 misses by $0.04.Revenue of $59.67M (+2.2% Y/Y) beats by $0.33M.Fiscal Year 2023 Guidance:Ward added, “Q1 results…
Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results 2022/11/03 11:00:00 Wallstreet:Online
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its first quarter, ended September 30, 2022. Executive Commentary – Scott Ward, Chairman, President and CEO “We are pleased with the state of
Cardiovascular Systems Q1 2023 Earnings Preview 2022/11/02 16:09:44 Seeking Alpha
Cardiovascular Systems (CSII) is scheduled to announce Q1 earnings results on Thursday, November 3rd, before market open.The consensus EPS Estimate is -$0.23 and the consensus Revenue…
Cardiovascular Systems, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:CSII) 2022/05/05 07:02:01 Seeking Alpha
The following slide deck was published by Cardiovascular Systems, Inc.
Cardiovascular Systems (CSII) Q3 2022 Earnings Call Transcript 2022/05/04 20:00:53 The Motley Fool
CSII earnings call for the period ending March 31, 2022.
Cardiovascular Systems GAAP EPS of -$0.25 beats by $0.03, revenue of $56.22M misses by $1.16M 2022/05/04 11:10:37 Seeking Alpha
Cardiovascular Systems press release (CSII): FQ3 GAAP EPS of -$0.25 beats by $0.03.Revenue of $56.22M (-11.1% Y/Y) misses by $1.16M.As of March 31, 2022, CSI had cash and…
Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results 2022/05/04 11:00:00 Business Wire
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its third quarter, ended March 31, 2022. Executive Commentary – Scott Ward, Chairman, President and CEO “Third quarter results were in line with our expectations. Despite the impact that Omicron had on hospital capacit